CDKN2A and neoplasm: Importantly, the loss of p16 expression is not exclusively dependent on the CN loss of CDKN2A but can also occur as a consequence of p16 promoter methylation [36,42,43] or miR-24 deregulation [44] and its loss correlates with tumor aggressiveness [36,45].